978 related articles for article (PubMed ID: 9015187)
21. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
22. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the AP-1 sites in the IL-2 promoter.
Jain J; Valge-Archer VE; Rao A
J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
25. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter.
Jalava A; Mai S
Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020
[TBL] [Abstract][Full Text] [Related]
26. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
27. PGE2 induces c-fos expression by a cAMP-independent mechanism in glomerular mesangial cells.
Simonson MS; Herman WH; Dunn MJ
Exp Cell Res; 1994 Nov; 215(1):137-44. PubMed ID: 7525323
[TBL] [Abstract][Full Text] [Related]
28. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts.
Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R
J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
[TBL] [Abstract][Full Text] [Related]
30. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.
Tugores A; Alonso MA; Sánchez-Madrid F; de Landázuri MO
J Immunol; 1992 Apr; 148(7):2300-6. PubMed ID: 1545132
[TBL] [Abstract][Full Text] [Related]
31. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
32. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
33. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation.
Kooijman R; Coppens A; Van den Keybus C
Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
36. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
37. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
38. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
Lin CW; Robbins PD; Georgescu HI; Evans CH
Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
[TBL] [Abstract][Full Text] [Related]
39. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
Hawker KL; Vass JK; Ozanne BW
Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
[TBL] [Abstract][Full Text] [Related]
40. Age-associated changes in basal c-fos transcription factor binding activity in rat hearts.
Tsou H; Azhar G; Lu XG; Kovacs S; Peacocke M; Wei JY
Exp Cell Res; 1996 Dec; 229(2):432-7. PubMed ID: 8986626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
